WallStreetZenWallStreetZen

NASDAQ: CABA
Cabaletta Bio Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Cabaletta Bio earnings were -$175.4M for the trailing 12 months ending Mar 31, 2026, with N/A growth year over year. The latest CABA earnings report on Mar 31, 2026 announced Q1 2026 earnings of -$43.5M, up 3.8% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, CABA reported annual earnings of -$167.9M, with 44.9% growth.

CABA earnings history

Current Revenue
$0.0
Current Earnings
-$175.4M
Current Profit Margin
0%

CABA Return on Equity

Current Company
-131.6%
Current Industry
-142.5%
Current Market
14%
CABA's Return on Equity (-131.6%)... subscribe to Premium to read more.
High Return on Equity Performance

CABA Return on Assets

Current Company
-96.5%
Current Industry
-13%
CABA is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when CABA announces earnings.

CABA Return on Capital Employed

Current Company
-162.31%
Current Industry
-9.2%
CABA's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

CABA vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
CABA-$153.56M-$175.43MN/A-$1.91
MDXG$54.47M$30.70M-36.45%$0.21
CADL-$49.96M-$54.42MN/A-$0.99
ALT-$88.27M-$91.08MN/A-$0.92
EIKNN/AN/AN/AN/A
View Top Biotech Stocks

Cabaletta Bio Earnings Reports & History FAQ

What were Cabaletta Bio's earnings last quarter?

On CABA's earnings call on Invalid Date, Cabaletta Bio (NASDAQ: CABA) reported Q1 2026 earnings per share (EPS) of -$0.39, up 45.07% year over year. Total CABA earnings for the quarter were -$43.52 million. In the same quarter last year, Cabaletta Bio's earnings per share (EPS) was -$0.71.

If you're new to stock investing, here's how to buy Cabaletta Bio stock.

Is Cabaletta Bio profitable or losing money?

As of the last Cabaletta Bio earnings report, Cabaletta Bio is currently losing money. Cabaletta Bio's net profit (also called net income) for the twelve months ending Mar 31, 2026 was -$175.43 million, a 38.39% increase year over year.

What was CABA's earnings growth in the past year?

As of Cabaletta Bio's earnings date in Invalid Date, Cabaletta Bio's earnings has grown year over year. CABA earnings in the past year totalled -$175.43 million.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.